相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。FXR expression in rats of hilar cholangiocarcinoma
Meng-yu Zhang et al.
SCIENTIFIC REPORTS (2022)
NTCP Change in Rats of Hilar Cholangiocarcinoma and Therapeutic Significance
Meng-yu Zhang et al.
TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2022)
Correlations between CD4+FoxP3+ Treg and expression of FoxM1 and Ki-67 in gastric cancer patients
Kai Ma et al.
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY (2021)
Cytotoxic CD8+T cells in cancer and cancer immunotherapy
Hans Raskov et al.
BRITISH JOURNAL OF CANCER (2021)
Prognostic impact of tumor microvessels in intrahepatic cholangiocarcinoma: association with tumor-infiltrating lymphocytes
Kyohei Yugawa et al.
MODERN PATHOLOGY (2021)
circPVT1 regulates medullary thyroid cancer growth and metastasis by targeting miR-455-5p to activate CXCL12/CXCR4 signaling
Xun Zheng et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)
Identification of Hub Genes and Their Correlation With Immune Infiltration Cells in Hepatocellular Carcinoma Based on GEO and TCGA Databases
Rui Huang et al.
FRONTIERS IN GENETICS (2021)
Therapeutic strategies targeting FOXO transcription factors
Giampaolo Calissi et al.
NATURE REVIEWS DRUG DISCOVERY (2021)
Advanced hilar cholangiocarcinoma: An aggressive surgical approach for the treatment of advanced hilar cholangiocarcinoma: Perioperative management, extended procedures, and multidisciplinary approaches
Takashi Mizuno et al.
SURGICAL ONCOLOGY-OXFORD (2020)
Gemcitabine enhances cytotoxic activity of effector T-lymphocytes against chemo-resistant cholangiocarcinoma cells
Nunghathai Sawasdee et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2020)
Immune cells within the tumor microenvironment: Biological functions and roles in cancer immunotherapy
Xu Lei et al.
CANCER LETTERS (2020)
FOXO transcription factor family in cancer and metastasis
Yannasittha Jiramongkol et al.
CANCER AND METASTASIS REVIEWS (2020)
TESC Promotes TGF-α/EGFR-FOXM1-Mediated Tumor Progression in Cholangiocarcinoma
Cheng-Han Hsieh et al.
CANCERS (2020)
Single-cell transcriptomic architecture and intercellular crosstalk of human intrahepatic cholangiocarcinoma
Min Zhang et al.
JOURNAL OF HEPATOLOGY (2020)
Peritumoral plasmacytoid dendritic cells predict a poor prognosis for intrahepatic cholangiocarcinoma after curative resection
Zhi-Qiang Hu et al.
CANCER CELL INTERNATIONAL (2020)
FOXM1 functions collaboratively with PLAU to promote gastric cancer progression
Chao Ai et al.
JOURNAL OF CANCER (2020)
Minimally invasive surgery for hilar cholangiocarcinoma: state of art and future perspectives
Hai-Jie Hu et al.
ANZ JOURNAL OF SURGERY (2019)
Regulatory T cells in cancer immunosuppression - implications for anticancer therapy
Yosuke Togashi et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2019)
Genomic testing, tumor microenvironment and targeted therapy of Hedgehog-related human cancers
Masaru Katoh
CLINICAL SCIENCE (2019)
Honokiol-enhanced cytotoxic T lymphocyte activity against cholangiocarcinoma cells mediated by dendritic cells pulsed with damage-associated molecular patterns
Arunya Jiraviriyakul et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2019)
Double-negative T Cells Inhibit Proliferation and Invasion of Human Pancreatic Cancer Cells in Co-culture
Yin Lu et al.
ANTICANCER RESEARCH (2019)
Surgical Considerations of Hilar Cholangiocarcinoma
Blaire Anderson et al.
SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA (2019)
CD8+ cytotoxic T lymphocytes in cancer immunotherapy: A review
Bagher Farhood et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
ADAM-17 is a poor prognostic indicator for patients with hilar cholangiocarcinoma and is regulated by FoxM1
Xiaodong Jiao et al.
BMC CANCER (2018)
Tight correlation between FoxM1 and FoxP3+Tregs in gastric cancer and their clinical significance
Xiaoxiao Li et al.
CLINICAL AND EXPERIMENTAL MEDICINE (2018)
Regulation of the master regulator FOXM1 in cancer
Guo-Bin Liao et al.
CELL COMMUNICATION AND SIGNALING (2018)
Overexpression of FoxM1 predicts poor prognosis of intrahepatic cholangiocarcinoma
Lingyun Liu et al.
AGING-US (2018)
FOXM1 in Cancer: Interactions and Vulnerabilities
Andrei L. Gartel
CANCER RESEARCH (2017)
The Immune System in Cancer Prevention, Development and Therapy
Serge M. Candeias et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2016)
Immunotherapy based on dendritic cells pulsed with CTP-FoxM1 fusion protein protects against the development of hepatocellular carcinoma
Huiting Su et al.
ONCOTARGET (2016)
Downregulation of FOXP3 inhibits invasion and immune escape in cholangiocarcinoma
Chao Ma et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
Manipulation of regulatory T cells and antigen-specific cytotoxic T lymphocyte-based tumour immunotherapy
Shirin Karimi et al.
IMMUNOLOGY (2015)
Perioperative Management of Hilar Cholangiocarcinoma
Katherine E. Poruk et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2015)
The expression of Nek7, FoxM1, and Plk1 in gallbladder cancer and their relationships to clinicopathologic features and survival
R. Wang et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2013)
Innate and adaptive immune cells in the tumor microenvironment
Thomas F. Gajewski et al.
NATURE IMMUNOLOGY (2013)
Tumor-Associated Macrophages Recruit CCR6+ Regulatory T Cells and Promote the Development of Colorectal Cancer via Enhancing CCL20 Production in Mice
Jinlin Liu et al.
PLOS ONE (2011)
The forkhead box M1 transcription factor as a candidate of target for anti-cancer immunotherapy
Kazunori Yokomine et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
PI3 kinase signalling blocks Foxp3 expression by sequestering Foxo factors
Matthias Merkenschlager et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Regulatory T-cell Trafficking: From Thymic Development to Tumor-Induced Immune Suppression
Adam W. Mailloux et al.
CRITICAL REVIEWS IN IMMUNOLOGY (2010)
分享论文
